non-linear curve fit routine Search Results


nonlinear curve fit gaussian function  (OriginLab corp)
90
OriginLab corp nonlinear curve fit gaussian function
Nonlinear Curve Fit Gaussian Function, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear curve fit gaussian function/product/OriginLab corp
Average 90 stars, based on 1 article reviews
nonlinear curve fit gaussian function - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
robust nonlinear regression analysis  (GraphPad Software Inc)
90
GraphPad Software Inc robust nonlinear regression analysis
Robust Nonlinear Regression Analysis, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/robust nonlinear regression analysis/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
robust nonlinear regression analysis - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear log inhibitor vs. normalized response curve fit function  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear log inhibitor vs. normalized response curve fit function
Non Linear Log Inhibitor Vs. Normalized Response Curve Fit Function, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear log inhibitor vs. normalized response curve fit function/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear log inhibitor vs. normalized response curve fit function - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nonlinear third-degree polynomial fit curve  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear third-degree polynomial fit curve
Nonlinear Third Degree Polynomial Fit Curve, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear third-degree polynomial fit curve/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear third-degree polynomial fit curve - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nonlinear curve fit tool of origin 2018  (OriginLab corp)
90
OriginLab corp nonlinear curve fit tool of origin 2018
Nonlinear Curve Fit Tool Of Origin 2018, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear curve fit tool of origin 2018/product/OriginLab corp
Average 90 stars, based on 1 article reviews
nonlinear curve fit tool of origin 2018 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nonlinear (sigmoidal) regression curve fit  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear (sigmoidal) regression curve fit
Nonlinear (Sigmoidal) Regression Curve Fit, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear (sigmoidal) regression curve fit/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear (sigmoidal) regression curve fit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear curve fit of percent cytotoxicity  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear curve fit of percent cytotoxicity
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Non Linear Curve Fit Of Percent Cytotoxicity, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear curve fit of percent cytotoxicity/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear curve fit of percent cytotoxicity - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
plateau followed by one phase decay equation  (GraphPad Software Inc)
90
GraphPad Software Inc plateau followed by one phase decay equation
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Plateau Followed By One Phase Decay Equation, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plateau followed by one phase decay equation/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
plateau followed by one phase decay equation - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
log(agonist) vs. response variable slope nonlinear curve fit in graphpadtm prism 5.01  (GraphPad Software Inc)
90
GraphPad Software Inc log(agonist) vs. response variable slope nonlinear curve fit in graphpadtm prism 5.01
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Log(Agonist) Vs. Response Variable Slope Nonlinear Curve Fit In Graphpadtm Prism 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/log(agonist) vs. response variable slope nonlinear curve fit in graphpadtm prism 5.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
log(agonist) vs. response variable slope nonlinear curve fit in graphpadtm prism 5.01 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
saturation binding curve  (GraphPad Software Inc)
90
GraphPad Software Inc saturation binding curve
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Saturation Binding Curve, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/saturation binding curve/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
saturation binding curve - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear curve fit using graphpad prizm version 9.3.1  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear curve fit using graphpad prizm version 9.3.1
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Non Linear Curve Fit Using Graphpad Prizm Version 9.3.1, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear curve fit using graphpad prizm version 9.3.1/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear curve fit using graphpad prizm version 9.3.1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
binding-saturation-one site-specific binding model  (GraphPad Software Inc)
90
GraphPad Software Inc binding-saturation-one site-specific binding model
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Binding Saturation One Site Specific Binding Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/binding-saturation-one site-specific binding model/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
binding-saturation-one site-specific binding model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative cytotoxicity observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.

Journal: Oncotarget

Article Title: Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model

doi: 10.18632/oncotarget.27544

Figure Lengend Snippet: ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative cytotoxicity observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.

Article Snippet: EC50 was determined by non-linear curve fit of percent cytotoxicity using GraphPad Prism 7.04 software (GraphPad Software).

Techniques: Enzyme-linked Immunosorbent Assay, Labeling, Binding Assay, Incubation, Control, Quantitation Assay, CTL Assay, Luciferase, Expressing, Activity Assay, Conjugation Assay